Abstract: The present invention relates to a method and a system of identifying biologically active molecules. Evaluating receptor or target suitability of molecules is an important task in pharmaceutical drug research. With the increasing employment of automation techniques over the last years within Drug Discovery processes, methods like High-Throughput-Screening (HTS) and High-Throughput-Synthesis have become industry standards in pharmaceutical research. Nowadays, it is possible to test more than 20,000 molecules per day for their biological activities in certain disease targets. Also in the area of chemical synthesis, combinatorial chemistry in combination with automation processes, hundreds of molecules per day can be made physically available.

Abstract: The present invention relates to a method and a system of identifying biologically active molecules. Evaluating receptor or target suitability of molecules is an important task in pharmaceutical drug research. With the increasing employment of automation techniques over the last years within Drug Discovery processes, methods like High-Throughput-Screening (HTS) and High-Throughput-Synthesis have become industry standards in pharmaceutical research. Nowadays, it is possible to test more than 20,000 molecules per day for their biological activities in certain disease targets. Also in the area of chemical synthesis, combinatorial chemistry in combination with automation processes, hundreds of molecules per day can be made physically available.